Comparison of leukemia-associated immunophenotype (LAIP)-based and different-from-normal (DfN)-based analysis of measurable residual disease (MRD) in patients with AML

Authors

von Bonin M; Bucklein V; Krause S; Volkl S; Rieger M; Berg T; Brendel C; Hoffmann J; Kramer M; Rohnert M

42(Suppl. 4): P353

Oncol Res Treat

Tobias Berg